6-Bromo-4-iodo-1H-indazole(CAS: 885519-41-5)

The compound 6-Bromo-4-iodo-1H-indazole (CAS: 885519-41-5) may be regulated under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) for hazardous properties such as flammability or reactivity. According to REACH regulations, it may need to be registered if the tonnage threshold is exceeded. FDA and EPA may also have specific requirements for its handling and disposal based on its intended use and potential environmental impact.

There are alternative reagents that can be used in the synthesis of 6-Bromo-4-iodo-1H-indazole (CAS: 885519-41-5), such as 4-bromo-6-iodo-1H-indazole or other indazole derivatives. These alternatives may offer similar functional groups but with different substituents, providing synthetic flexibility and potentially reducing the need for specialized handling or disposal methods.

The market and research trends for 6-Bromo-4-iodo-1H-indazole (CAS: 885519-41-5) are currently focused on its potential use in medicinal chemistry and drug discovery. It is being explored for its anti-inflammatory and antimicrobial properties. The trend indicates a growing interest in understanding its biological activity and developing new derivatives with enhanced efficacy and reduced side effects.

Waste containing 6-Bromo-4-iodo-1H-indazole (CAS: 885519-41-5) should be collected in appropriate containers and stored in a well-ventilated area away from incompatible materials. Professional waste disposal services should be used to ensure safe incineration or chemical treatment to neutralize any hazardous properties before disposal. Proper environmental protection measures, including the use of personal protective equipment, should be followed to prevent contamination and exposure during handling and disposal.